Pre–CAR-T B-cell–directed immunotherapy exposure and outcomes after CD19 CAR-T for large B-cell lymphoma: An EBMT registry analysis
Jan C. Schroeder, Christophe Peczynski, Philipp Berning, Eva Michel et autres
0 citationsBone Marrow Transplantation
Norbert Schmitz
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
650Publications signalées
33877Citations signalées
2Affiliations récentes
Institutions déclarées
Domaines associés
Lymphoma Diagnosis and TreatmentChronic Lymphocytic Leukemia ResearchHematopoietic Stem Cell TransplantationCAR-T cell therapy researchAcute Lymphoblastic Leukemia research
Publications récentes
Haematopoietic stem cell transplantation in hepatosplenic T-cell lymphoma: a retrospective analysis of the EBMT Lymphoma Working Party
Imke E. Karsten, Norbert Schmitz, Mathilde Fekom, Laurence de Leval et autres
0 citationsThe Lancet Haematology
Allogeneic hematopoietic cell transplantation for T-cell/histiocyte-rich large B-cell lymphoma: An EBMT lymphoma working party study.
Simon Renders, Maud Ngoya, Laurence de Leval, Hervé Finel et autres
0 citationsOpen Access CRIS of the University of Bern
Autologous and allogeneic haematopoietic cell transplantation in adult patients with Hodgkin lymphoma: recommendations from the EBMT Practice Harmonisation and Guidelines Committee and Lymphoma Working Party
Ali Bazarbachi, Ranjana Advani, Sairah Ahmed, Carmelo Carlo-Stella et autres
0 citationsThe Lancet Haematology
The impact of IPI risk factors on CAR T-cell therapy or allogeneic stem cell transplantation for treatment of relapsed or refractory large B-cell lymphoma (LBCL)
Anna Ossami Saidy, Ariane Boumendil, Peter Dreger, Federico Stella et autres
0 citationsBone Marrow Transplantation
Allogeneic hematopoietic cell transplantation for T-cell/histiocyte-rich large B-cell lymphoma: An EBMT lymphoma working party study
Simon Renders, Maud Ngoya, Laurence de Leval, Hervé Finel et autres
0 citationsLeukemia
Impact of Perforin 1 A91V germ line background in patients with aggressive B-NHL treated with R-CHOP
Onur Cetin, Igor Age Kos, Evi Regitz, Moritz Bewarder et autres
0 citationsBlood Advances
Integration of high-throughput proteomic data and complementary omics layers with PriOmics
Robin Kosch, Katharina Limm, Annette M. Staiger, Nadine S. Kurz et autres
0 citationsGenome Research
Impact of prior B-cell-directed immunotherapy on the outcome of CD19 CAR T-cell therapy in aggressive B-cell lymphoma - an analysis of the EBMT and the GoCART coalition
Jan C. Schroeder, Christophe Peczynski, Philipp Berning, Eva Michel et autres
0 citationsBlood
Impact of PRF 1 A91V germline carrier status in patients with aggressive b-NHL treated with rituximab
Onur Cetin, Igor Age Kos, Evi Regitz, Moritz Bewarder et autres
0 citationsBlood
Autologous and allogeneic stem cell transplantation for ALK-positive anaplastic large cell lymphoma: An analysis of the EBMT lymphoma working party
Evgenii Shumilov, Maud Ngoya, Philipp Berning, Irma Khvedelidze et autres
0 citationsBlood
Impact of extranodal involvement in stage I aggressive B-cell lymphoma in the rituximab era: An individual patient data meta-analysis of two Phase III dshnhl/GLA trials
Konstantinos Christofyllakis, Vadim Lesan, Moritz Bewarder, Bettina Altmann et autres
0 citationsBlood
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.